Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

AT&T reported for 6 months of 2023

7/26/23 T

Saratovenergo reported for 6 months of 2023 by RAS

7/26/23 SARE

General Dynamics reported for 6 months of 2023

7/26/23 GD

Coca-Cola reported for 6 months of 2023

7/26/23 KO

Ozon will build in Tula region a logistics center with an area of 60 thousand square meters

7/26/23 OZON

LSR reported for 6 months of 2023 by RAS

7/26/23 LSRG

Rosseti Volga reported for 6 months of 2023 by RAS

7/26/23 MRKV

Sollers may start production of tourist buses

7/26/23 SVAV

Ozon started construction of the largest logistics hub in Kazakhstan

7/26/23 OZON

TMK's Board of Directors recommended dividends for 6 months of 2023

7/26/23 TRMK